Tsukuba, Japan

Nobuhiro Sato

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuhiro Sato. Retrieved from https://idiyas.com/inventor/nobuhiro-sato-gva0pj42

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Nobuhiro Sato

Introduction

Nobuhiro Sato is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of three patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Sato's latest patents include innovative compounds such as pentacyclic heterocycles. These compounds are represented by formulas (I) to (XVII) or their pharmaceutically acceptable salts. Another notable patent is for a pentacyclic compound, which is also represented by formulas (1) to (VI) or their pharmaceutically acceptable salts. These inventions highlight his commitment to advancing pharmaceutical science.

Career Highlights

Nobuhiro Sato is currently employed at Eisai R&D Management Co., Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to the advancement of medical treatments. His expertise in the field has positioned him as a valuable asset to his organization.

Collaborations

Sato has collaborated with notable colleagues, including Yoshiaki Ohashi and Yoshihiko Norimine. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Nobuhiro Sato's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect his dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…